Geode Capital Management
DMK

Geode Capital Management’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Geode Capital Management’s Portfolio DMK Stock Details DMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-71,098
Closed -$49.8K – 4703
2023
Q4 		$49.8K Buy
71,098
+17,056
+32% +$9.9K ﹤0.01% 4351
2023
Q3 		$37.2K Buy
54,042
+35,095
+185% +$44.9K ﹤0.01% 4491
2023
Q2 		$45.3K Sell
18,947
-5
-0% -$21 ﹤0.01% 4525
2023
Q1 		$154K Hold
18,952
– – ﹤0.01% 4168
2022
Q4 		$224K Sell
18,952
-1,091
-5% -$12.5K ﹤0.01% 4040
2022
Q3 		$278K Buy
20,043
+537
+3% +$13.9K ﹤0.01% 4030
2022
Q2 		$684K Buy
19,506
+1,030
+6% +$32.1K ﹤0.01% 3586
2022
Q1 		$738K Hold
18,476
– – ﹤0.01% 3753
2021
Q4 		$782K Sell
18,476
-580
-3% -$36.2K ﹤0.01% 3832
2021
Q3 		$1.29M Buy
19,056
+683
+4% +$50K ﹤0.01% 3554
2021
Q2 		$1.41M Buy
18,373
+2,988
+19% +$182K ﹤0.01% 3433
2021
Q1 		$1.01M Buy
15,385
+7,407
+93% +$577K ﹤0.01% 3560
2020
Q4 		$270K Buy
7,978
+821
+11% +$36.5K ﹤0.01% 3795
2020
Q3 		$392K Sell
7,157
-2,342
-25% -$139K ﹤0.01% 3501
2020
Q2 		$357K Buy
9,499
+488
+5% +$16.7K ﹤0.01% 3482
2020
Q1 		$225K Buy
9,011
+15
+0.2% +$637 ﹤0.01% 3515
2019
Q4 		$441K Buy
8,996
+4,179
+87% +$203K ﹤0.01% 3545
2019
Q3 		$237K Hold
4,817
– – ﹤0.01% 3709
2019
Q2 		$438K Buy
4,817
+448
+10% +$54.5K ﹤0.01% 3510
2019
Q1 		$645K Buy
4,369
+64
+1% +$12.4K ﹤0.01% 3332
2018
Q4 		$677K Buy
4,305
+686
+19% +$132K ﹤0.01% 3257
2018
Q3 		$886K Buy
3,619
+947
+35% +$224K ﹤0.01% 3268
2018
Q2 		$598K Buy
2,672
+178
+7% +$47.7K ﹤0.01% 3375
2018
Q1 		$610K Hold
2,494
– – ﹤0.01% 3332
2017
Q4 		$768K Hold
2,494
– – ﹤0.01% 3202
2017
Q3 		$912K Buy
2,494
+735
+42% +$261K ﹤0.01% 3164
2017
Q2 		$640K Buy
1,759
+538
+44% +$161K ﹤0.01% 3271
2017
Q1 		$363K Buy
1,221
+368
+43% +$92.9K ﹤0.01% 3440
2016
Q4 		$188K Hold
853
– – ﹤0.01% 3639
2016
Q3 		$204K Hold
853
– – ﹤0.01% 3594
2016
Q2 		$167K Buy
853
+259
+44% +$119K ﹤0.01% 3652
2016
Q1 		$254 Hold
594
– – ﹤0.01% 3550
2015
Q4 		$224K Hold
594
– – ﹤0.01% 3641
2015
Q3 		$164K Hold
594
– – ﹤0.01% 3750
2015
Q2 		$174K Hold
594
– – ﹤0.01% 3630
2015
Q1 		$163K Buy
594
+86
+17% +$37.1K ﹤0.01% 3644
2014
Q4 		$219K Hold
508
– – ﹤0.01% 3545
2014
Q3 		$166K Hold
508
– – ﹤0.01% 3634
2014
Q2 		$170K Buy
508
+207
+69% +$81.3K ﹤0.01% 3563
2014
Q1 		$133K Buy
+301
New +$137K ﹤0.01% 3606

Other funds holding DMK

CPA
Clear Point Advisors Melville, New York $129M AUM 12.02% 1-Year Est. Return
OPTFSNA
Old Point Trust & Financial Services N A Newport News, Virginia $311M AUM 24.14% 1-Year Est. Return

Geode Capital Management's DMK Position: Q1 2024 in Review

Geode Capital Management sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q1 2024, closing a stake of 71,098 shares — an estimated $49.8K sold.

Geode Capital Management first reported a position in DMK in Q1 2014 and held it in 40 quarters. The position peaked at $1.41M in Q2 2021. 3 funds tracked by Wall St. Rank hold DMK as of Q1 2024.

  • Geode Capital Management reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q1 2024 after selling out during the quarter.
  • Geode Capital Management sold 71,098 DMK Pharmaceuticals Corporation Common Stock shares in Q1 2024, an estimated $49.8K.
  • Geode Capital Management first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q1 2014 and held it in 40 quarters.
  • Geode Capital Management's DMK Pharmaceuticals Corporation Common Stock position peaked at $1.41M in Q2 2021.
  • 3 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q1 2024.

Based on Geode Capital Management's 13F filing for Q1 2024, filed 13 May 2024.